Earnings
SXTC
0.3450
+6.15%
0.0200
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-03-31
7.29M
--
--
3.82M
--
--
5.88M
--
1.05M
--
--
1.60M
19.64M
1.90M
--
--
--
--
50.05K
--
112.84K
2.07M
21.70M
--
1.94M
43.90K
--
--
--
--
--
635.14K
--
--
--
3.00M
12.26M
36.51K
--
--
--
--
36.52K
12.30M
34.67K
17.16M
-7.20M
--
--
--
9.40M
9.40M
21.70M
FY 2019-03-31
9.13M
--
--
4.18M
--
--
81.26K
--
1.33M
--
--
868.42K
15.59M
1.81M
--
--
--
--
61.10K
--
13.50K
1.88M
17.47M
--
1.69M
261.15K
--
--
--
--
--
485.63K
--
--
--
3.89M
6.32M
41.71K
--
--
--
41.71K
41.71K
6.36M
22.71K
7.95M
3.08M
--
--
--
11.11M
11.11M
17.47M
FY 2018-03-31
560.25K
--
--
2.60M
--
--
688.08K
--
1.49M
--
--
757.17K
6.10M
1.49M
--
--
--
--
60.67K
--
6170.00
1.56M
7.66M
--
2.41M
385.12K
--
--
--
--
--
163.93K
--
--
--
1.42M
4.37M
0.00
--
--
--
--
0.00
4.37M
20.00K
1.46M
1.54M
--
--
--
3.29M
3.29M
7.66M
FY 2017-03-31
65.57K
--
--
2.74M
--
--
1.03M
--
1.02M
--
--
50.06K
4.91M
485.29K
--
--
--
--
41.00K
--
0.00
526.29K
5.43M
--
1.26M
302.17K
--
--
--
--
--
152.17K
--
--
--
1.86M
3.58M
0.00
--
--
--
--
0.00
3.58M
20.00K
1.46M
357.06K
--
--
--
1.85M
1.85M
5.43M
FY 2016-03-31
11.44K
--
--
1.95M
--
--
1.79M
--
1.72M
--
--
271.59K
5.73M
430.08K
--
--
--
--
41.40K
--
--
471.48K
6.21M
--
2.89M
375.63K
--
--
--
--
--
176.10K
--
--
--
2.02M
5.46M
0.00
--
--
--
--
0.00
5.46M
20.00K
1.46M
-828.08K
--
--
--
742.77K
742.77K
6.21M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out SXTC latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze CHINA SXT PHARMACEUTICALS, INC. recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.